The DOI matches its Crossref record; 280 of the 286 references it cites were found in a registry or an index.
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, there is likely no lower limit on the amount of moderate-to-vigorous physical activity at which benefits for ASCVD risk start to accrue, and effort should be made to promote achievement of the minimum recommended amount of physical activity (44).”
From 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation
Research works printed but not linked: 13
- DeFilippis, 2017, Eur Heart J, 38, 598
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
- Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
- Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 · DOI
- Nasir, 2015, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 · DOI
- Yano, 2017, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies, JAMA Cardiol, 2, 986, 10.1001/jamacardio.2017.2498 · DOI
- Budoff, 2018, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA), Eur Heart J, 39, 2401, 10.1093/eurheartj/ehy217 · DOI · Paper page
- Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
- Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 · DOI · Paper page
- Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI
- Patnode, 2015, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force, Ann Intern Med, 163, 608, 10.7326/M15-0171 · DOI · Paper page
- Guirguis-Blake, 2016, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 804, 10.7326/M15-2113 · DOI
Cited by
Sorted by citations
Items 701–800 of 1,000
Nasoufidou, A., Glava, A., Mavridou, M., Stachteas, P., Karagiannidis, E., Patoulias, D., Kassimis, G., Fragakis, N., & Kavga, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176018 · Cited by 4
Tsutsumi, T., Charlton, M., Oddo, V. M., Vilt, S., Kim, H. Y., Micić, D., Odenwald, M. A., Kawaguchi, T., McDonald, E., & Rinella, M. E. (2025) · Hepatology Research · doi:10.1111/hepr.70075 · Cited by 4
An integrated germline and somatic genomic model for coronary artery disease
Yang, X., Kim, M. S., Zhu, X., Uddin, M. M., Nakao, T., Cho, S. M. J., Koyama, S., Xu, T., Reeskamp, L. F., Zhang, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70379-2 · Cited by 4
Self-citationThe role of sleep in cardiovascular health and disease risk
Bian, W., Cistulli, P. A., Chaput, J., Biswas, R. K., Koemel, N. A., Ahmadi, M., & Stamatakis, E. (2026) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2026.07.001 · Cited by 5
Jian, W., Dong, Z., Shen, X., Zheng, Z., Wu, Z., Shi, Y., Han, Y., Du, J., & Liu, J. (2024) · European Radiology · doi:10.1007/s00330-024-10629-3 · Cited by 4
Rountree, L., Fukuoka, Y., Sagae, K., Zhang, J., Pike, N. A., Brecht, M., Rezk‐Hanna, M., & DeVon, H. A. (2024) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001151 · Cited by 4
Мухтаровна, М. Д., Junusbekova, G., Tundybayeva, M. K., Leonovich, T., Сайлаубековна, Б. Л., Ismailov, E. M., & Samitova, S. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00412-w · Cited by 4
Vo, V.-A. D., Khalil, M. K., & Al‐Hasan, M. N. (2021) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2021.100079 · Cited by 4
“Risk factors for AMI or AIS following BSI in this cohort included wellestablished cardiovascular and cerebrovascular risk factors in the general population (older age, prior CAD or stroke, and hypertension) [16].”
BackgroundHyperlipidemia: effective disease management with a focus on PCSK9 inhibitors
Shaw, P. B. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88606 · Cited by 4
Drug-related problems at the heart of cardiac surgery
Çakır, B. K., Aydin, A. B., Yılmaz, M., & Bayraktar‐Ekincioglu, A. (2023) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2022-003669 · Cited by 4
Reasons for antiretroviral switching in Colombia: A retrospective cohort study
Valderrama, S., Martínez-Vernaza, S., Forero, S. V. C., Jaimes-Reyes, M. A., Arévalo-Mora, L., Martínez, E., Franco, J., Beltrán-Rodríguez, C., Urrego-Reyes, J., Leon, S., et al. (2023) · International Journal of STD & AIDS · doi:10.1177/09564624231181156 · Cited by 4
Huang, H., Kuang, Z., Mo, R., Meng, M., Cai, Y., & Ni, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1227450 · Cited by 4
Clinician use of the Statin Choice Shared Decision-making Encounter Tool in a Major Health System
Martinez, K. A., Montori, V. M., Rodríguez, F., Tereshchenko, L. G., Kovach, J. D., Hurwitz, H., & Rothberg, M. B. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08597-3 · Cited by 4
Lam, R., Manemann, S. M., Seehusen, K. E., Remaley, A. T., Sauver, J. L. S., Jiang, R., Killian, J. M., Sampson, M. L., Meeusen, J. W., Decker, P. A., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02188-9 · Cited by 4
“Patients who may not have been recommended pharmacotherapy may now meet the requirements; conversely, those who previously met the requirements may fall below the threshold [14].”
BackgroundHeald, A. H., Mannan, F., Wiltshire, R., Ghaffari, P., Waheed, U., Zdravković, D., Bashir, B., Syed, A. A., Donn, R. P., & Soran, H. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01627-1 · Cited by 4
Guo, Z., Fu, Y., Wang, X., Monroe, A. A., Zhang, Y., Jin, J., & Chen, M.-F. (2024) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2024.10.011 · Cited by 4
Wu, C., Chen, X., Yang, L., Sun, H., Bao, S., Li, H., Zheng, L., Zeng, H., Li, R., & Peng, Y. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.25 · Cited by 5
Zeng, G., Wang, H., Cao, P., Zhao, J., Liu, L., & Guo, H. (2025) · BMC Public Health · doi:10.1186/s12889-024-21183-4 · Cited by 4
Ferreira, N. V., Bittencourt, M. S., Generoso, G., Gonçalves, N. G., Barreto, S. M., Giatti, L., Santos, R. D., Lotufo, P. A., Benseñor, I. M., & Suemoto, C. K. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119159 · Cited by 5
Statin-Associated muscle symptoms and vitamin D supplementation
Fadah, K., Mares, A. C., & Lange, R. A. (2025) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001222 · Cited by 4
Bejjani, A., Khairani, C. D., Krishnathasan, D., Rizzo, S. M., Sato, A., Bacare, B., Scimeca, G., Tristani, A., Armero, A., Porio, N. D., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf109 · Cited by 5
Clasey, J. L., Adams, A. M., Geiger, P. J., Segerstrom, S. C., & Crofford, L. J. (2020) · Women s Health Reports · doi:10.1089/whr.2020.0045 · Cited by 4
Lee, M., Mahtta, D., Alam, M., Ullah, W., Nasir, K., Hanif, B., & Virani, S. S. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1888718 · Cited by 4
Self-citationAssociation and diagnostic value of a novel uric acid index to cardiovascular risk
Rojas-Humpire, R., Jáuregui-Rodríguez, K., Albornoz, S., Mamani, P. G. R., Gutierrez-Ajalcriña, R., & Huancahuire‐Vega, S. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00247 · Cited by 4
Lu, Q., Zhang, R.-C., Chen, S., Li, T., Wang, Y., Xue, Y., Liu, J., Han, X., Su, Y., Bai, L., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.748875 · Cited by 4
Composite Biomarkers for Assessing Frailty Status in Stable Older Adults With Cardiovascular Disease
Hirashiki, A., Shimizu, A., Suzuki, N., Nomoto, K., Kokubo, M., Hashimoto, K., Sato, K., Kondo, I., Murohara, T., & Arai, H. (2022) · Circulation Reports · doi:10.1253/circrep.cr-21-0143 · Cited by 4
Dietary fat intake and quality in long-term care residents in two cohorts assessed 10 years apart
Jyväkorpi, S. K., Merja, H. S., Strandberg, T. E., Salminen, K., Niskanen, R. T., Roitto, H., Riitta, K. T. S., & Pitkälä, K. H. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00524-9 · Cited by 4
A Chronic Inflammatory Inductive Condition in the Nursing Profession: A Scoping Review
Vitale, E. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220516163936 · Cited by 4
New cardiovascular events in the convalescent period among survivors of SARS-CoV-2 infection
Qureshi, A. I., Baskett, W. I., Huang, W., Akıncı, Y., Suri, M. F. K., Naqvi, S. H., French, B. R., Siddiq, F., Gomez, C. R., & Shyu, C. (2022) · International Journal of Stroke · doi:10.1177/17474930221114561 · Cited by 4
Jiménez-Baladó, J., Llena, I. R., Nafría, C., Pizarro, J., Rodríguez‐Luna, D., Maisterra, O., Ballvé, A., Mundet, X., Violán, C., Ventura, O., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003154 · Cited by 5
Serum Lipoprotein(a) and 3-Year Outcomes in Patients Undergoing Percutaneous Coronary Intervention
Corpataux, N., Hochholzer, W., Valina, C. M., Ferenc, M., Löffelhardt, N., Westermann, D., Neumann, F., & Nührenberg, T. G. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101362 · Cited by 4
Langton, C. R., Whitcomb, B. W., Purdue‐Smithe, A., Harmon, Q. E., Hankinson, S. E., Manson, J. E., ROSNER, B. A., & Bertone‐Johnson, E. R. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.10.003 · Cited by 5
Ghorashi, S. M., Ahmadi, P., Khalesi, R. S. N., Fazeli, A. M., Vardanjani, H. M., Salehi, A., Omidi, N., Shams, M., & Babaei, A. (2023) · The Journal of Tehran University Heart Center · doi:10.18502/jthc.v18i1.12578 · Cited by 4
An, L., Qin, J., Jiang, W., Luo, P., Luo, X., Lai, Y., & Jin, M. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1257388 · Cited by 4
Hazim, A. Z., Nhola, L. F., Kailash, V., Zhang, S., Sandhu, N. P., Lerman, A., Loprinzi, C. L., Ruddy, K. J., Villarraga, H. R., Lewis, B. R., et al. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead130 · Cited by 4
“3 Furthermore, vasoreactivity/endothelial function assessment might be useful, reflecting the impact of CV risk factors on the CV system.”
BackgroundWeir-McCall, J. R., Nicol, E. D., Abbara, S., Branch, K. R., Choi, A., Ghoshhajra, B. B., Leipsic, J. A., Nieman, K., Shaw, L. J., & Blankstein, R. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2019.12.034 · Cited by 4
Douthit, N. T., Wyatt, N. E., & Schwartz, B. H. (2021) · Cureus · doi:10.7759/cureus.14856 · Cited by 4
Oldenburg, O., & Spießhoefer, J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.055 · Cited by 4
Prevention of Cardiovascular Disease — Don’t Stop Thinking about Tomorrow
Blumenthal, R. S., & Martin, S. S. (2024) · New England Journal of Medicine · doi:10.1056/nejme2409080 · Cited by 4
Self-citationExercise interventions for older patients with frailty and heart failure: A scoping review
Liu, S., Zhang, M., Xiong, X.-Y., Chen, L., & Wu, R. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.03.050 · Cited by 3
Yang, J., & Park, B. (2025) · BMC Public Health · doi:10.1186/s12889-025-23431-7 · Cited by 3
Jukema, R., Nasibi, N., Mueller, A. S., Kim, S., Argulian, E., Khoo, J. K., Binzaid, A. A., Rigby, H., Pashaee, B., Danad, I., et al. (2025) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2025.08.008 · Cited by 3
Petek, B., Mo, M., Xu, H., Norgren, J., Hoang, M. T., Villa‐Lopez, M., Häbel, H., Kele, J., Naia, L., Maioli, S., et al. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251385903 · Cited by 3
“58,60,61 Statin therapy is recommended for adults with established cardiovascular disease, regardless of age.”
Lipoprotein(a) and long-term structural valve degeneration of aortic bioprostheses
Boute, M., Salembier, P., Pouleur, A., Pasquet, A., Gerber, B. L., Azevedo, D. D., Gruson, D., de Kerchove, L., Kefer, J., Beauloye, C., et al. (2025) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeaf320 · Cited by 3
Artificial Intelligence in Coronary Computed Tomography
Giarletta, L., Zhou, B., Marano, R., Cecco, C. N. D., & van Assen, M. (2026) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000873 · Cited by 4
Metabolic Stress and Immune Activation in Heart Failure With a Preserved Ejection Fraction
Pereira, A., Alvarez‐Argote, S., Meite, I., Inui, H., Sterling, J. K., Thorp, E. J., Feinstein, M. J., Filipp, M., & Thorp, E. B. (2026) · Immunological Reviews · doi:10.1111/imr.70103 · Cited by 4
Solé, G., Camdessanché, J., Attarian, S., Ciumas, M., Blein, C., Grenier, B., Herquelot, É., & Echaniz‐Laguna, A. (2026) · European Journal of Neurology · doi:10.1111/ene.70504 · Cited by 3
Polygenic risk scores enhance LDL cholesterol–based risk stratification for coronary artery disease
Harper, C., Misra, A., Patel, A. P., Cho, S. M. J., Koyama, S., Peloso, G. M., Hornsby, W., Nakao, T., & Natarajan, P. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101487 · Cited by 4
“The current paradigm of primary prevention of CAD centers on forecasting patients ’ 10-year risk of developing atherosclerotic cardiovascular disease (ASCVD) using validated clinical risk scores to identify high-risk individuals for targeted intervention [2 – 4].”
Panagiotakos, D. B., Tsamoulis, D., Bouratzis, V., Leventis, I., Kalantzis, C., Tasoulas, D., Kalogeras, P., Malkots, B., Daios, S., Zormpas, G., et al. (2026) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2026.2706281 · Cited by 3
Grossmann, K., Aeschbacher, S., Wohlwend, N., Blum, S., Weideli, O. C., Telser, J., Risch, M., Risch, L., & Conen, D. (2022) · Applied Sciences · doi:10.3390/app12199777 · Cited by 3
Hashimoto, R., Murakami, T., Kamimura, R., Matsuki, T., & Seki, K. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2106173 · Cited by 3
Kim, S. P., Ryu, J., Kim, S. H., & Yoon, H. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.03.009 · Cited by 3
Time trends in income-related disparity in incidence of acute coronary syndrome
Simoni, A. H., Kragholm, K. H., Bøggild, H., Jensen, S. E., Valentin, J. B., & Johnsen, S. P. (2023) · European Journal of Public Health · doi:10.1093/eurpub/ckad139 · Cited by 3
Mekonene, M., Gebremedhin, S., Bikila, D., Ashebir, G., & Baye, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075893 · Cited by 3
Rodriguez, C. P., Ogunmoroti, O., Minhas, A. S., Vaidya, D. M., Kazzi, B. E., Osibogun, O. I., Whelton, S. P., Kovell, L. C., Harrington, C. M., Honigberg, M. C., et al. (2023) · PubMed Central · Cited by 3
Self-citationMultidisciplinary management of cardiovascular disease in women: Delphi consensus
Gámez, J. M., Pérez, M. P., Olmo, M. R. F., Fasero, M., Inaraja, V., & Pallarés‐Carratalá, V. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1315503 · Cited by 4
Shen, R., & Zou, T. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09845-6 · Cited by 3
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy
Theilen, L. H., Varner, M. W., Esplin, M. S., & Horne, B. D. (2024) · Pregnancy Hypertension · doi:10.1016/j.preghy.2024.101122 · Cited by 4
Iqbal, O., Shah, H., Sosa, A., Kulinski, J. P., Cross, R. K., & Sinh, P. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.07.019 · Cited by 3
Volpp, K. G. M., Mahraj, K., Norton, L., Asch, D. A., Glanz, K., Mehta, S. J., Balasta, M. A., Kellum, W. E., Wood, J. C., Russell, L., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.09.029 · Cited by 3
Liebermann, P., & Defrin, R. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001195 · Cited by 3
“Physical exercise is an important component of health promotion and disease prevention programs 2,46 as well as pain management and rehabilitation, 36,47 and it is often the preferred intervention given pain medications’ adverse effects.”
BackgroundTheilen, L. H., Kimball, E. R., Galyean, P. O., Vanneman, M. E., Varner, M. W., Silver, R. M., & Zickmund, S. L. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18154 · Cited by 3
Suzuki, T., Sato, T., Tanaka, M., Nakata, K., Endo, K., Aida, H., Kawaharata, W., Hosaka, I., Umetsu, A., Ogawa, T., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1496671 · Cited by 5
A contemporary paradigm for value-based medicine in peripheral artery disease
Raskin, D., Partovi, S., Mills, J. L., Clair, D. G., Khan, M. A. S., Lyden, S. P., & Kirksey, L. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.08.001 · Cited by 4
Emerging therapies targeting lipoprotein(a): Pharmacologic advances and future directions
Perez, A. D., Simpson, R. J., Komé, A. M., & Lopez, S. T. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103695 · Cited by 3
Chalikias, G. K., Serif, L., Thomaidis, A., Lantzouraki, A., Stakos, D., & Tziakas, D. N. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.025 · Cited by 3
Lozano, P. R., & Bourque, J. M. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02441-5 · Cited by 3
The pharmacological management of cardiovascular disease in people living with HIV (PLWH)
Corbacho, N., Mur, I., Molas, M. E., Vidal, F., & Domingo, P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1856075 · Cited by 4
Use of cardiovascular imaging in risk restratification of the diabetic patient
Bellinge, J. W., Lee, S. C., & Schultz, C. J. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000611 · Cited by 3
Martins, P. R. T., Moreira, A. S. B., dos Santos, E. M., Rodrigues, L. F., & Weber, B. (2021) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20200087 · Cited by 3
Hirashiki, A., Shimizu, A., Suzuki, N., Nomoto, K., Kokubo, M., Sugimoto, T., Hashimoto, K., Sato, K., Sakurai, T., Murohara, T., et al. (2022) · International Heart Journal · doi:10.1536/ihj.21-377 · Cited by 3
Blood-Based and Imaging Biomarkers of Atherosclerosis
Ali, K., Lang, C. C., Huang, J. T. J., & Choy, A. M. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000442 · Cited by 3
Female risk factors for post-myocardial infarction depression and anxiety (FRIDA): Pilot results
Liblik, K., Hu, R., Gomes, Z., Foldes‐Busque, G., Mensour, E., Sedlak, T., Mulvagh, S. L., & Johri, A. M. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.05.005 · Cited by 3
Anokye, R., Jackson, B., Dimmock, J. A., Dickson, J. M., Blekkenhorst, L. C., Hodgson, J. M., Lewis, J. R., & Stanley, M. J. (2022) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvac047 · Cited by 4
Rasooly, D., Yang, Q., Moonesinghe, R., Khoury, M. J., & Patel, C. J. (2022) · Public Health Genomics · doi:10.1159/000526242 · Cited by 3
Jamiel, A. A., Ardah, H. I., Ahmed, A. M., & Al-Mallah, M. H. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01174-5 · Cited by 3
Divakaran, S., Lopez, D. M., Parks, S. M., Hainer, J. M., Ng, A. K., Blankstein, R., Carli, M. F. D., & Nohria, A. (2023) · Cardio-Oncology · doi:10.1186/s40959-023-00157-2 · Cited by 3
Liu, X., Zhang, J., Li, P., Han, P., Kang, Y. J., & Zhang, W. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231151968 · Cited by 3
Yoo, T. K., Lee, S., Rhim, H. C., Lee, M. Y., Cheong, E., Seo, M. H., & Sung, K. (2023) · Medicina · doi:10.3390/medicina59030522 · Cited by 4
Jean-Marie, E. M., Tashtish, N., Albar, Z., Miller, D., Sullivan, C., Al-Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100492 · Cited by 3
Effects of statin therapies on individuals taking antipsychotics: a systematic review
Ferrell, M. C., Ernst, Z., Ferrell, S. C., Jaiswal, D. D., & Vassar, M. B. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001489 · Cited by 3
Sperstad, S. B., Sæther, J. C., Klevjer, M., Giskeødegård, G. F., Bathen, T. F., Røsbjørgen, R. E. N., Dalen, H., & Bye, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285355 · Cited by 3
Wang, Y., Liang, Y., Seth, I., Wu, G., Du, Z., Huang, Y., Shang, X., Liu, S., Hu, Y., Fang, Y., et al. (2023) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000612 · Cited by 3
Wang, Y., Bulloch, G., Huang, Y., Liang, Y., Du, Z., Wu, G., Fang, Y., Hu, Y., Shang, X., Zhu, Z., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01152-4 · Cited by 3
Nazir, M. S., Murphy, T. M., Poku, N. K., Wheen, P., Nowbar, A. N., Andrés, M. S., Ramalingam, S., Rosen, S. D., Nicol, E. D., & Lyon, A. R. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.08.121 · Cited by 3
Peppa, Μ., Manta, A., Mavroeidi, I., Asimakopoulou, A., Syrigos, A., Nastos, C., Pikoulis, E. A., & Κόλλιας, Α. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112526 · Cited by 3
Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score
Chaudhry, W. A. R., Ashfaq, M., Kaur, P., Kumar, M., Faraz, M., Malik, J., & Mehmoodi, A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001652 · Cited by 3
“These guidelines advise the consideration of these conditions as risk enhancers or modi fi ers, thereby strengthening the case for implementing chronic statin therapy among patients who are at the cusp of borderline or intermediate risk for ASCVD [57,58] .”
BackgroundWang, K., Wang, W., Niu, J., Liu, X., Han, H., Shen, H., Sun, Y., Gao, W., & Ge, H. (2024) · Angiology · doi:10.1177/00033197241239688 · Cited by 4
Shavkuta, G. V., & Туркина, С. В. (2024) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2024-5-2-29-37 · Cited by 3
Yin, K., Chen, W., Qin, G., Liang, J., Bao, X., Yu, H., Li, H., Xu, J., Chen, X., Wang, Y., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-247 · Cited by 3
Zhou, Y., Qiao, Y., Zhao, L., Zhang, X., Yang, S., Bai, L., & Liu, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-73661-9 · Cited by 3
Comprehensive estimation model for the health economic impact of the residential environment
Kamata, T., Nakano, J., Fujii, R., Murakami, S., Ikaga, T., & Kawakubo, S. (2024) · Building and Environment · doi:10.1016/j.buildenv.2024.112233 · Cited by 3
Nurse-led atrial fibrillation clinics in primary health care: a review of the evidence
Dahlberg, M., & Jakobsson, U. (2025) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2025.2466175 · Cited by 5
“…vascular disease is to promote a healthy life-style throughout life, and team-based care is an effective strategy for this preventive approach [7]. an early intervention of risk factors is found to reduce the incidence of aF. the significant morbidity and mortality associated with aF, as well…”
Bueno, C. O. P., España, J. A. B., Guzmán, C. M., Díaz‐Brochero, C., & Peña, Á. A. G. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.04.197 · Cited by 3
Direct Oral Anticoagulants and Coronary Artery Disease: The Debacle of the Aspirin Era?
García‐Ropero, Á., Vargas-Delgado, A. P., Santos‐Gallego, C. G., & Badimón, J. J. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000795 · Cited by 3
PILLAY, S., Schwellnus, M. P., GRANT, C., RENSBURG, A. J. V., SWANEVELDER, S., & JORDAAN, E. (2022) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.21.12072-9 · Cited by 3
Pushing the New NIH LDL-Cholesterol Equation to Its Limits
Higgins, V., Delaney, S. R., & Beriault, D. R. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab064 · Cited by 3
Sun, K.-H., Yang, M.-F., Xu, X.-R., Li, Y., Gao, Z., Zhang, Q., Li, H., Wang, S., Lou, L.-X., Wu, A., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4604601 · Cited by 3
“According to the guideline, lipid-lowering drugs are the firstline drugs for the secondary prevention of coronary heart disease, and statins are the most widely used lipid-lowering drugs in clinical practice [3].”
BackgroundHow low should one go in reducing carbohydrate?
Kirkpatrick, C. F., Agarwala, A., & Maki, K. C. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.10.007 · Cited by 3
Metadata
- Authors
- Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 74
- Issue
- 10
- Pages
- 1376-1414
- ISSN
- 0735-1097 (ISSN-L)
- PMC
- PMC8344373
- OpenAlex
- W2984766121
- Cited by
- 1,193
- References
- 286
- Citations by year
- 2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
- FWCI
- 153.80
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association (17SDG33630113)
- National Institutes of Health (KL2TR001882)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review